Pulike Biological Engineering Inc operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pulike Biological Engineering Inc with three other
companies in this sector in China:
Nanjing King-Friend Biochemical Pharmaceutical Co Ltd
sales of 581.89 million Chinese Renmimbi [US$92.75 million]
Zhenxing Biopharmaceutical & Chemical Co Ltd
(567.44 million Chinese Renmimbi [US$90.44 million]
of which 100%
was Pharmaceutical Sales), and
Walvax Biotechnology Company Limited
(590.16 million Chinese Renmimbi [US$94.07 million]
of which 38%
was Autonomous Vaccine).